Literature DB >> 12139226

A high malaria reinfection rate in children and young adults living under a low entomological inoculation rate in a periurban area of Bamako, Mali.

Issaka Sagara1, Djibril Sangaré, Guimogo Dolo, Aldiouma Guindo, Mamady Sissoko, Moussa Sogoba, Mohamed B Niambélé, Daniel Yalcoué, David C Kaslow, Alassane Dicko, Amy D Klion, Dapa Diallo, Louis H Miller, Yeya Touré, Ogobara Doumbo.   

Abstract

In areas of intense malaria parasite transmission, preliminary studies of the rate of reinfection after curative therapy suggest that small sample size studies of vaccine efficacy are feasible. However, the effect of transmission rate, which may vary considerably between transmission seasons, on reinfection rate has not been assessed in areas of mesoendemicity with seasonal transmission. To address this question, the Plasmodium falciparum reinfection rate after curative therapy was measured in Sotuba, a Malian village with historically low transmission rates, as estimated by the entomological inoculation rate (EIR). The reinfection rate after curative Fansidar (sulfadoxine-pyrimethamine) treatment was 80.7% (88/109). The EIR during the 13-week study period (seasonal transmission) varied between 1 and 4.5 infected bites/person/month. The finding that reinfection rates were high despite low EIRs suggests that a low EIR may be sufficient to support small sample size vaccine efficacy trials in mesoendemic areas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12139226     DOI: 10.4269/ajtmh.2002.66.310

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  15 in total

1.  Development of clinical immunity to malaria in highland areas of low and unstable transmission.

Authors:  Melissa A Rolfes; Matthew McCarra; Ng'wena G Magak; Kacey C Ernst; Arlene E Dent; Kim A Lindblade; Chandy C John
Journal:  Am J Trop Med Hyg       Date:  2012-09-17       Impact factor: 2.345

2.  What can we learn from an unnatural immune response?

Authors:  Brandy Lee Bennett; Photini Sinnis
Journal:  Trends Parasitol       Date:  2010-04-27

3.  Innate immunity induced by Plasmodium liver infection inhibits malaria reinfections.

Authors:  Peter Liehl; Patrícia Meireles; Inês S Albuquerque; Mykola Pinkevych; Fernanda Baptista; Maria M Mota; Miles P Davenport; Miguel Prudêncio
Journal:  Infect Immun       Date:  2015-01-12       Impact factor: 3.441

4.  Dendritic cells and the malaria pre-erythrocytic stage.

Authors:  Marjorie Mauduit; Peter See; Kaitian Peng; Laurent Rénia; Florent Ginhoux
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

5.  Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage.

Authors:  Elodie Belnoue; Tatiana Voza; Fabio T M Costa; Anne Charlotte Grüner; Marjorie Mauduit; Daniela Santoro Rosa; Nadya Depinay; Michèle Kayibanda; Ana Margarida Vigário; Dominique Mazier; Georges Snounou; Photini Sinnis; Laurent Rénia
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

6.  Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial.

Authors:  Alassane Dicko; Abdoulbaki I Diallo; Intimbeye Tembine; Yahia Dicko; Niawanlou Dara; Youssoufa Sidibe; Gaoussou Santara; Halimatou Diawara; Toumani Conaré; Abdoulaye Djimde; Daniel Chandramohan; Simon Cousens; Paul J Milligan; Diadier A Diallo; Ogobara K Doumbo; Brian Greenwood
Journal:  PLoS Med       Date:  2011-02-01       Impact factor: 11.069

7.  A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.

Authors:  Philip Bejon; Jedidah Mwacharo; Oscar Kai; Tabitha Mwangi; Paul Milligan; Stephen Todryk; Sheila Keating; Trudie Lang; Brett Lowe; Caroline Gikonyo; Catherine Molyneux; Greg Fegan; Sarah C Gilbert; Norbert Peshu; Kevin Marsh; Adrian V S Hill
Journal:  PLoS Clin Trials       Date:  2006-10-20

8.  Assessment of the relative success of sporozoite inoculations in individuals exposed to moderate seasonal transmission.

Authors:  Adama Tall; Cheikh Sokhna; Ronald Perraut; Didier Fontenille; Laurence Marrama; Alioune B Ly; Fatoumata D Sarr; Aïssatou Toure; Jean-François Trape; André Spiegel; Christophe Rogier; Pierre Druilhe
Journal:  Malar J       Date:  2009-07-15       Impact factor: 2.979

9.  Early whole blood transcriptional responses to radiation-attenuated Plasmodium falciparum sporozoite vaccination in malaria naïve and malaria pre-exposed adult volunteers.

Authors:  Fergal J Duffy; Ying Du; Jason Carnes; Judith E Epstein; Stephen L Hoffman; Salim Abdulla; Said Jongo; Maxmillian Mpina; Claudia Daubenberger; John D Aitchison; Ken Stuart
Journal:  Malar J       Date:  2021-07-09       Impact factor: 2.979

10.  Spatial variability in the density, distribution and vectorial capacity of anopheline species in a high transmission village (Equatorial Guinea).

Authors:  Jorge Cano; Miguel Angel Descalzo; Marta Moreno; Zhaoguo Chen; Sisinio Nzambo; Leonardo Bobuakasi; Jesús N Buatiche; Melchor Ondo; Francisco Micha; Agustín Benito
Journal:  Malar J       Date:  2006-03-23       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.